Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indra N Guha

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Diabetologia|March 31, 2015
γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes StudyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
European Journal of Gastroenterology & Hepatology|October 24, 2012
Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhageDavid J Harman, Roger B McCorry, Ruth P Jacob, et al.
Journal of Hepatology|February 12, 2014
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Indra N Guha, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2019
Validation of the AASLD recommendations for classification of oesophageal varices in clinical practiceWaleed Fateen, Krish Ragunath, Jonathan White, et al.
Hepatology (Baltimore, Md.)|August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver diseaseSudeep Tanwar, Paul M Trembling, Indra N Guha, et al.
NMR in Biomedicine|April 25, 2015
A study of T₁ relaxation time as a measure of liver fibrosis and the influence of confounding histological factorsCaroline L Hoad, Naaventhan Palaniyappan, Philip Kaye, et al.
Gastroenterology|January 29, 2019
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver DiseasePeter J Eddowes, Magali Sasso, Michael Allison, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Scientific Reports|August 7, 2019
Publisher Correction: SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosisVarinder S Athwal, James Pritchett, Katherine Martin, et al.
Scientific Reports|December 19, 2018
SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosisVarinder S Athwal, James Pritchett, Katherine Martin, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Diabetologia|March 31, 2015
γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes StudyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
European Journal of Gastroenterology & Hepatology|October 24, 2012
Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhageDavid J Harman, Roger B McCorry, Ruth P Jacob, et al.
Journal of Hepatology|February 12, 2014
Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Indra N Guha, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2019
Validation of the AASLD recommendations for classification of oesophageal varices in clinical practiceWaleed Fateen, Krish Ragunath, Jonathan White, et al.
Hepatology (Baltimore, Md.)|August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver diseaseSudeep Tanwar, Paul M Trembling, Indra N Guha, et al.
NMR in Biomedicine|April 25, 2015
A study of T₁ relaxation time as a measure of liver fibrosis and the influence of confounding histological factorsCaroline L Hoad, Naaventhan Palaniyappan, Philip Kaye, et al.
Gastroenterology|January 29, 2019
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver DiseasePeter J Eddowes, Magali Sasso, Michael Allison, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
Scientific Reports|August 7, 2019
Publisher Correction: SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosisVarinder S Athwal, James Pritchett, Katherine Martin, et al.
Scientific Reports|December 19, 2018
SOX9 regulated matrix proteins are increased in patients serum and correlate with severity of liver fibrosisVarinder S Athwal, James Pritchett, Katherine Martin, et al.
Pageof 3